Cite
Martínez-Martínez E, Gómez I, Martín P, et al. Cannabinoids receptor type 2, CB2, expression correlates with human colon cancer progression and predicts patient survival. Oncoscience. 2015;2(2):131-41doi: 10.18632/oncoscience.119.
Martínez-Martínez, E., Gómez, I., Martín, P., Sánchez, A., Román, L., Tejerina, E., Bonilla, F., Merino, A. G., de Herreros, A. G., Provencio, M., & García, J. M. (2015). Cannabinoids receptor type 2, CB2, expression correlates with human colon cancer progression and predicts patient survival. Oncoscience, 2(2), 131-41. https://doi.org/10.18632/oncoscience.119
Martínez-Martínez, Esther, et al. "Cannabinoids receptor type 2, CB2, expression correlates with human colon cancer progression and predicts patient survival." Oncoscience vol. 2,2 (2015): 131-41. doi: https://doi.org/10.18632/oncoscience.119
Martínez-Martínez E, Gómez I, Martín P, Sánchez A, Román L, Tejerina E, Bonilla F, Merino AG, de Herreros AG, Provencio M, García JM. Cannabinoids receptor type 2, CB2, expression correlates with human colon cancer progression and predicts patient survival. Oncoscience. 2015 Feb 09;2(2):131-41. doi: 10.18632/oncoscience.119. eCollection 2015. PMID: 25859556; PMCID: PMC4381706.
Copy
Download .nbib